Lipopharma Therapeutics SL - Product Pipeline Review - 2013 - New Study Released
Fast Market Research recommends "Lipopharma Therapeutics SL - Product Pipeline Review - 2013" from Global Markets Direct, now available
Boston, MA -- (SBWire) -- 08/20/2013 --Global Market Direct's pharmaceuticals report, "Lipopharma Therapeutics SL - Product Pipeline Review - 2013" provides data on the Lipopharma Therapeutics SL's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Lipopharma Therapeutics SL's corporate website, SEC filings, investor presentations and featured press releases, both from Lipopharma Therapeutics SL and industry-specific third party sources, put together by Global Markets Direct's team.
View Full Report Details and Table of Contents
- Lipopharma Therapeutics SL - Brief Lipopharma Therapeutics SL overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Lipopharma Therapeutics SL human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Lipopharma Therapeutics SL with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Lipopharma Therapeutics SL's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to Get This Report
- Evaluate Lipopharma Therapeutics SL's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Lipopharma Therapeutics SL in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Lipopharma Therapeutics SL's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Lipopharma Therapeutics SL.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Lipopharma Therapeutics SL and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Lipopharma Therapeutics SL - Product Pipeline Review - 2012
- Nektar Therapeutics - Product Pipeline Review - 2013
- Addex Therapeutics - Product Pipeline Review - 2013
- Parkinson's Disease - Pipeline Review, H1 2013
- United Therapeutics Corporation - Product Pipeline Review - 2013
- Sarepta Therapeutics, Inc. - Product Pipeline Review - 2013
- Onconova Therapeutics, Inc - Product Pipeline Review - 2013
- Advinus Therapeutics Ltd. - Product Pipeline Review - 2013
- Chroma Therapeutics Ltd. - Product Pipeline Review - 2013
- Pain Therapeutics, Inc. - Product Pipeline Review - 2013
Media Relations Contact
Director of Marketing
View this press release online at: http://rwire.com/304001